0001209191-12-042119.txt : 20120816 0001209191-12-042119.hdr.sgml : 20120816 20120816143100 ACCESSION NUMBER: 0001209191-12-042119 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120815 FILED AS OF DATE: 20120816 DATE AS OF CHANGE: 20120816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN JACK CENTRAL INDEX KEY: 0001230729 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 033-80623 FILM NUMBER: 121039645 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1522 217TH PLACE S.E. CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254879500 MAIL ADDRESS: STREET 1: 1522 217TH PLACE S.E. CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2012-08-15 0 0000949858 ONCOGENEX PHARMACEUTICALS, INC. OGXI 0001230729 GOLDSTEIN JACK 1522 217TH PLACE SE SUITE 100 BOTHELL WA 98021 1 0 0 0 Common Stock 2012-08-15 4 P 0 1000 14.381 A 1000 D Sandra Thomson as attorney-in-fact for Jack Goldstein 2012-08-16